Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 11 |
GO:0005849 | mRNA cleavage factor complex | 3 | 11 |
GO:0032991 | protein-containing complex | 1 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
GO:0140513 | nuclear protein-containing complex | 2 | 11 |
Related structures:
AlphaFold database: A4I1W6
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 11 |
GO:0006378 | mRNA polyadenylation | 7 | 11 |
GO:0006396 | RNA processing | 6 | 11 |
GO:0006397 | mRNA processing | 7 | 11 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 11 |
GO:0006807 | nitrogen compound metabolic process | 2 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0016070 | RNA metabolic process | 5 | 11 |
GO:0016071 | mRNA metabolic process | 6 | 11 |
GO:0031123 | RNA 3'-end processing | 7 | 11 |
GO:0031124 | mRNA 3'-end processing | 8 | 11 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 11 |
GO:0043170 | macromolecule metabolic process | 3 | 11 |
GO:0043631 | RNA polyadenylation | 6 | 11 |
GO:0044237 | cellular metabolic process | 2 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0046483 | heterocycle metabolic process | 3 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:0090304 | nucleic acid metabolic process | 4 | 11 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 11 |
GO:0003723 | RNA binding | 4 | 11 |
GO:0003729 | mRNA binding | 5 | 11 |
GO:0005488 | binding | 1 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
GO:0003824 | catalytic activity | 1 | 2 |
GO:0016787 | hydrolase activity | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 121 | 123 | PF00675 | 0.277 |
CLV_NRD_NRD_1 | 131 | 133 | PF00675 | 0.207 |
CLV_PCSK_FUR_1 | 119 | 123 | PF00082 | 0.333 |
CLV_PCSK_KEX2_1 | 121 | 123 | PF00082 | 0.333 |
CLV_PCSK_KEX2_1 | 58 | 60 | PF00082 | 0.334 |
CLV_PCSK_PC1ET2_1 | 58 | 60 | PF00082 | 0.334 |
CLV_PCSK_SKI1_1 | 136 | 140 | PF00082 | 0.248 |
DOC_CDC14_PxL_1 | 252 | 260 | PF14671 | 0.445 |
DOC_CYCLIN_RxL_1 | 132 | 141 | PF00134 | 0.519 |
DOC_MAPK_gen_1 | 208 | 218 | PF00069 | 0.505 |
DOC_PP4_FxxP_1 | 44 | 47 | PF00568 | 0.549 |
DOC_USP7_MATH_1 | 125 | 129 | PF00917 | 0.501 |
DOC_USP7_MATH_1 | 154 | 158 | PF00917 | 0.474 |
DOC_USP7_MATH_1 | 203 | 207 | PF00917 | 0.509 |
DOC_USP7_MATH_1 | 38 | 42 | PF00917 | 0.585 |
DOC_WW_Pin1_4 | 188 | 193 | PF00397 | 0.519 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.493 |
LIG_BIR_III_4 | 95 | 99 | PF00653 | 0.556 |
LIG_BRCT_BRCA1_1 | 40 | 44 | PF00533 | 0.534 |
LIG_BRCT_MDC1_1 | 267 | 271 | PF00533 | 0.575 |
LIG_Clathr_ClatBox_1 | 215 | 219 | PF01394 | 0.533 |
LIG_FHA_1 | 110 | 116 | PF00498 | 0.484 |
LIG_FHA_2 | 105 | 111 | PF00498 | 0.498 |
LIG_FHA_2 | 157 | 163 | PF00498 | 0.474 |
LIG_FHA_2 | 16 | 22 | PF00498 | 0.573 |
LIG_LIR_Apic_2 | 110 | 116 | PF02991 | 0.469 |
LIG_LIR_Apic_2 | 184 | 188 | PF02991 | 0.486 |
LIG_LIR_Apic_2 | 41 | 47 | PF02991 | 0.488 |
LIG_LIR_Gen_1 | 221 | 231 | PF02991 | 0.533 |
LIG_LIR_Nem_3 | 221 | 227 | PF02991 | 0.533 |
LIG_LIR_Nem_3 | 246 | 251 | PF02991 | 0.467 |
LIG_LYPXL_S_1 | 194 | 198 | PF13949 | 0.253 |
LIG_LYPXL_yS_3 | 195 | 198 | PF13949 | 0.453 |
LIG_SH2_CRK | 113 | 117 | PF00017 | 0.505 |
LIG_SH2_CRK | 248 | 252 | PF00017 | 0.453 |
LIG_SH2_GRB2like | 242 | 245 | PF00017 | 0.441 |
LIG_SH2_NCK_1 | 242 | 246 | PF00017 | 0.445 |
LIG_SH2_SRC | 197 | 200 | PF00017 | 0.453 |
LIG_SH2_SRC | 242 | 245 | PF00017 | 0.505 |
LIG_SH2_STAT5 | 15 | 18 | PF00017 | 0.445 |
LIG_SH2_STAT5 | 197 | 200 | PF00017 | 0.442 |
LIG_SH2_STAT5 | 214 | 217 | PF00017 | 0.536 |
LIG_SH2_STAT5 | 223 | 226 | PF00017 | 0.460 |
LIG_SH2_STAT5 | 266 | 269 | PF00017 | 0.488 |
LIG_SH3_3 | 193 | 199 | PF00018 | 0.445 |
LIG_SH3_3 | 231 | 237 | PF00018 | 0.533 |
LIG_SH3_3 | 40 | 46 | PF00018 | 0.607 |
LIG_SUMO_SIM_anti_2 | 229 | 235 | PF11976 | 0.556 |
LIG_SUMO_SIM_anti_2 | 70 | 76 | PF11976 | 0.444 |
LIG_UBA3_1 | 53 | 58 | PF00899 | 0.484 |
LIG_UBA3_1 | 83 | 87 | PF00899 | 0.523 |
MOD_CK2_1 | 104 | 110 | PF00069 | 0.516 |
MOD_CK2_1 | 203 | 209 | PF00069 | 0.531 |
MOD_CK2_1 | 45 | 51 | PF00069 | 0.313 |
MOD_GlcNHglycan | 152 | 155 | PF01048 | 0.305 |
MOD_GlcNHglycan | 40 | 43 | PF01048 | 0.693 |
MOD_GlcNHglycan | 47 | 50 | PF01048 | 0.298 |
MOD_GSK3_1 | 150 | 157 | PF00069 | 0.516 |
MOD_GSK3_1 | 16 | 23 | PF00069 | 0.608 |
MOD_GSK3_1 | 163 | 170 | PF00069 | 0.425 |
MOD_GSK3_1 | 218 | 225 | PF00069 | 0.535 |
MOD_GSK3_1 | 98 | 105 | PF00069 | 0.501 |
MOD_N-GLC_1 | 13 | 18 | PF02516 | 0.527 |
MOD_N-GLC_1 | 167 | 172 | PF02516 | 0.283 |
MOD_N-GLC_1 | 243 | 248 | PF02516 | 0.306 |
MOD_N-GLC_2 | 265 | 267 | PF02516 | 0.355 |
MOD_NEK2_2 | 203 | 208 | PF00069 | 0.533 |
MOD_PIKK_1 | 13 | 19 | PF00454 | 0.559 |
MOD_Plk_1 | 109 | 115 | PF00069 | 0.477 |
MOD_Plk_1 | 125 | 131 | PF00069 | 0.523 |
MOD_Plk_4 | 156 | 162 | PF00069 | 0.484 |
MOD_Plk_4 | 181 | 187 | PF00069 | 0.519 |
MOD_Plk_4 | 218 | 224 | PF00069 | 0.513 |
MOD_ProDKin_1 | 188 | 194 | PF00069 | 0.519 |
TRG_DiLeu_BaEn_1 | 126 | 131 | PF01217 | 0.467 |
TRG_DiLeu_BaEn_1 | 229 | 234 | PF01217 | 0.556 |
TRG_DiLeu_BaEn_1 | 70 | 75 | PF01217 | 0.467 |
TRG_DiLeu_BaEn_4 | 126 | 132 | PF01217 | 0.484 |
TRG_ENDOCYTIC_2 | 195 | 198 | PF00928 | 0.453 |
TRG_ENDOCYTIC_2 | 223 | 226 | PF00928 | 0.505 |
TRG_ENDOCYTIC_2 | 248 | 251 | PF00928 | 0.453 |
TRG_ER_diArg_1 | 119 | 122 | PF00400 | 0.533 |
TRG_Pf-PMV_PEXEL_1 | 136 | 141 | PF00026 | 0.264 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I415 | Leptomonas seymouri | 77% | 100% |
A0A0S4IS07 | Bodo saltans | 40% | 94% |
A0A1X0NU79 | Trypanosomatidae | 51% | 93% |
A0A3R7NXV8 | Trypanosoma rangeli | 52% | 92% |
A0A3S7WZJ5 | Leishmania donovani | 99% | 100% |
A4HEN7 | Leishmania braziliensis | 86% | 100% |
C9ZS54 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 49% | 90% |
E9AY11 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
O43809 | Homo sapiens | 30% | 100% |
Q3ZCA2 | Bos taurus | 30% | 100% |
Q4KM65 | Rattus norvegicus | 30% | 100% |
Q4Q9G2 | Leishmania major | 94% | 100% |
Q55E68 | Dictyostelium discoideum | 29% | 100% |
Q5RAI8 | Pongo abelii | 30% | 100% |
Q6DJE4 | Xenopus laevis | 30% | 100% |
Q7T3C6 | Danio rerio | 31% | 100% |
Q8GXS3 | Arabidopsis thaliana | 32% | 100% |
Q94AF0 | Arabidopsis thaliana | 31% | 100% |
Q9CQF3 | Mus musculus | 30% | 100% |